Ion Mobility-enabled Data-dependent Experiments Distinguishing Co-eluting Isomeric Metabolites Using an IMS-QTof Mass Spectrometer

Significance of the Topic

Ion mobility-enabled data-dependent acquisition (IMS-DDA) addresses a critical challenge in drug metabolite analysis: the separation and confident identification of co-eluting, isomeric metabolites that traditional LC-MS/MS DDA cannot resolve. By adding an orthogonal drift time dimension, IMS-DDA yields cleaner MS and MS/MS spectra, reducing spectral interference and improving structural assignment.

Objectives and Study Overview

This application note evaluates the performance of IMS-enabled DDA on a Vion IMS QTof mass spectrometer for distinguishing co-eluting glucuronides of dihydroxylated nefazodone metabolites. The study compares conventional m/z-only DDA with IMS-DDA, demonstrating enhanced selectivity and spectral clarity.

Methodology and Instrumentation

Sample preparation involved incubation of nefazodone (10 µM) with rat hepatocytes at 37 °C, sampling up to 140 minutes, protein precipitation, and centrifugation.

Chromatography and mass spectrometry conditions:

• UPLC: Waters ACQUITY I-Class with HSS T3 column (2.1×50 mm, 1.8 µm), 4 min gradient, 0.65 mL/min flow, 45 °C column.
• Mobile phases: water/0.1% formic acid and acetonitrile/0.1% formic acid.
• MS: Vion IMS QTof with ESI+, reference lockmass leucine enkephalin at m/z 556.27658.
• DDA parameters: full scan (m/z 50–1200, 0.1 s), MS/MS triggered by m/z inclusion list, intensity threshold 1,000 counts, up to two concurrent MS/MS events, 1 s timeout, collision energy ramp 15–50 eV.
• IMS-DDA: drift time filtering integrated with quadrupole selection for high-selectivity MS/MS.

Key Results and Discussion

Traditional DDA produced mixed product ion spectra for two glucuronides co-eluting at ~0.84 min. IMS-DDA separated these isomers by drift times (9.56 vs. 10.13 ms), generating distinct MS/MS spectra. Comparison of fragment ions revealed a key difference at low mass: m/z 306.14 (first isomer) versus 290.15 (second isomer), indicating a hydroxyl moiety variation. The drift time filter also removed background ions, yielding cleaner precursor spectra and simplifying interpretation.

Benefits and Practical Applications

• Enhanced selectivity: dual m/z and drift time triggers isolate isomeric metabolites.
• Improved confidence: cleaner spectra facilitate unambiguous structural assignments.
• Streamlined workflows: integration with UNIFI software supports automated pathway profiling and data visualization.

Future Trends and Potential Applications

Expanding IMS-DDA to broader metabolite classes and complex biological matrices can further improve discovery and targeted assays. Coupling with quantitative IMS workflows and machine-learning–driven spectral deconvolution may accelerate metabolite identification in drug development and clinical research.

Conclusion

IMS-enabled DDA on the Vion IMS QTof enhances metabolite characterization by resolving co-eluting isomeric species through drift time discrimination. This approach delivers high-selectivity MS/MS spectra, boosting confidence in metabolite structural elucidation and supporting robust drug metabolism studies.

References

1. Bonn B, Leandersson C, Fontaine F, Zamora I. Enhanced metabolite identification with MSE and a semi-automated software for structural elucidation. Rapid Communications in Mass Spectrometry. 2010;24:3127–3138.
2. Clayton R, Holdsworth C, Tomczyk N, Palmer M, Weston D. Resolution and characterisation of co-eluting isomeric metabolites by collisional cross section measurements using a novel geometry travelling wave IMS QTof device. Poster presented at ASMS 2016.